Loading...
Loading...
NEW YORK, NY · CIK 0001263508
New positions
10
Added to
20
Trimmed
11
Exited
8
BAKER BROS. ADVISORS LP (NEW YORK, NY) reported a portfolio value of $17.28B across 107 positions in their Q2 2023 SEC 13F filing (period ending 2023-06-30). The top 10 positions account for 87.6% of the portfolio.
Top 30 holdings by portfolio weight. Block width = holding percentage. Green = new/increased, red = reduced, gray = unchanged.
| # | Stock | Value↓ | Weight | Change |
|---|---|---|---|---|
| 1 | SGENUSDSeagen Inc. | $8.57B | 49.63% | -5.0% |
| 2 | INCYIncyte Corporation | $2.25B | 13.03% | +0.0% |
| 3 | ONCBeiGene, Ltd. | $2.08B | 12.04% | - |
| 4 | ACADACADIA Pharmaceuticals Inc. | $1.03B | 5.94% | +2.2% |
| 5 | MDGLMadrigal Pharmaceuticals, Inc. | $356.92M | 2.07% | - |
| 6 | BMRNBioMarin Pharmaceutical Inc. | $330.27M | 1.91% | - |
| 7 | IMCRImmunocore Holdings plc | $151.14M | 0.87% | - |
| 8 | Invitae Corporation | $135.00M | 0.78% | New |
| 9 | KODKodiak Sciences Inc. | $119.44M | 0.69% | - |
| 10 | AKROAkero Therapeutics, Inc. | $110.58M | 0.64% | - |
| Stock | Value | Shares |
|---|---|---|
| Invitae Corporation | $135.00M | 300,000,000 |
| IMGNEURImmunoGen, Inc. | $28.68M | 1,520,097 |
| DAWNGBXDay One Biopharmaceuticals, Inc. | $11.94M | 1,000,000 |
| COGTCogent Biosciences, Inc. | $11.60M | 979,600 |
| VSTMVerastem, Inc. | $9.94M | 1,336,485 |
| MREOMereo BioPharma Group PLC | $4.69M | 3,554,979 |
| Gracell Biotechnologies Inc. | $3.81M | 1,000,000 |
| CYPHLeap Therapeutics, Inc. | $3.67M | 1,172,175 |
| TLISTalis Biomedical Corporation | $3.66M | 7,624,835 |
| ISREURPerspective Therapeutics, Inc. | $1.55M | 2,319,286 |
Get alerts when BAKER BROS. ADVISORS LP files new 13F holdings.